|
|
Blood, 1 April 2004, Vol. 103, No. 7, pp. 2530-2540.
Prepublished online as a Blood First Edition Paper on December 4, 2003; DOI 10.1182/blood-2003-09-3209.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Differential gene expression of human stem progenitor cells derived from early stages of in utero human hematopoiesis
Farbod Shojaei,
Lisa Gallacher, and
Mickie Bhatia
From the Robarts Research Institute, Stem Cell Biology and Regenerative Medicine, London, ON, Canada; and Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada.
Hematopoietic stem progenitor cells (HSPCs) are highly enriched in a rare subset of Lin-CD34+CD38- cells. Independent of stage of human development, HSPC function segregates to the subset of Lin-CD34+CD38- cells. However, fetal-derived HSPCs demonstrate distinct self-renewal and differentiation capacities compared with their adult counterparts. Here, to characterize the molecular nature of fetal HSPCs, suppressive subtractive hybridization was used to compare gene expression of HSPCs isolated from fetal blood (FB-HSPCs) versus adult mobilized peripheral blood (MPB-HSPCs). We identified 97 differentially expressed genes that could be annotated into distinct groups that include transcription factors, cell cycle regulators, and genes involved in signal transduction. Candidate regulators, such as Lim only domain-2 (LMO2), nuclear factor–kappa B (NF- B), tripartite motif 28 (Trim28), and N-myc protooncogene (MYCN), and a novel homeobox gene product were among transcripts that were found to be differentially expressed and could be associated with specific proliferation and differentiation properties unique to FB-HSPCs. Interestingly, the majority of genes associated with signal transduction belong to Ras pathway, highlighting the significance of Ras signaling in FB-HSPCs. Genes differentially expressed in FB-HSPCs versus adult MPB-HSPCs were verified using quantitative real-time polymerase chain reaction (Q-PCR). This approach also resulted in the identification of a transcript that is highly expressed in FB-HSPCs but not detectable in more differentiated Lin-CD34+CD38+ FB progenitors. Our investigation represents the first study to compare phenotypically similar, but functionally distinct, HSPC populations and to provide a gene profile of unique human HSPCs with higher proliferative capacity derived from early in utero human blood development.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Xiao, C. E. Inal, V. I. Parekh, C.-M. Chang, and M. H. Whitnall
5-Androstenediol Promotes Survival of {gamma}-Irradiated Human Hematopoietic Progenitors through Induction of Nuclear Factor-{kappa}B Activation and Granulocyte Colony-Stimulating Factor Expression
Mol. Pharmacol.,
August 1, 2007;
72(2):
370 - 379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Panepucci, R. T. Calado, V. Rocha, R. Proto-Siqueira, W. A. Silva Jr., and M. A. Zago
Higher Expression of Transcription Targets and Components of the Nuclear Factor-{kappa}B Pathway Is a Distinctive Feature of Umbilical Cord Blood CD34+ Precursors
Stem Cells,
January 1, 2007;
25(1):
189 - 196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Pilon, D. G. Nilson, D. Zhou, J. Sangerman, T. M. Townes, D. M. Bodine, and P. G. Gallagher
Alterations in expression and chromatin configuration of the alpha hemoglobin-stabilizing protein gene in erythroid kruppel-like factor-deficient mice.
Mol. Cell. Biol.,
June 1, 2006;
26(11):
4368 - 4377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. Moneypenny, J. Shao, Y. Song, and E. P. Gallagher
MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells
Carcinogenesis,
April 1, 2006;
27(4):
874 - 881.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Jaatinen, H. Hemmoranta, S. Hautaniemi, J. Niemi, D. Nicorici, J. Laine, O. Yli-Harja, and J. Partanen
Global Gene Expression Profile of Human Cord Blood-Derived CD133+ Cells
Stem Cells,
March 1, 2006;
24(3):
631 - 641.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Toren, B. Bielorai, J. Jacob-Hirsch, T. Fisher, D. Kreiser, O. Moran, S. Zeligson, D. Givol, A. Yitzhaky, J. Itskovitz-Eldor, et al.
CD133-Positive Hematopoietic Stem Cell "Stemness" Genes Contain Many Genes Mutated or Abnormally Expressed in Leukemia
Stem Cells,
September 1, 2005;
23(8):
1142 - 1153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Komor, S. Guller, C. D. Baldus, S. de Vos, D. Hoelzer, O. G. Ottmann, and W.-K. Hofmann
Transcriptional Profiling of Human Hematopoiesis During In Vitro Lineage-Specific Differentiation
Stem Cells,
September 1, 2005;
23(8):
1154 - 1169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wang, L. Li, P. Menendez, C. Cerdan, and M. Bhatia
Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development
Blood,
June 15, 2005;
105(12):
4598 - 4603.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ioannidis, L. G. Mahaira, S. A. Perez, A. D. Gritzapis, P. A. Sotiropoulou, G. J. Kavalakis, A. I. Antsaklis, C. N. Baxevanis, and M. Papamichail
CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells
J. Biol. Chem.,
May 20, 2005;
280(20):
20086 - 20093.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
